Literature DB >> 29248654

Value of Myocardial Perfusion Assessment With Coronary Computed Tomography Angiography in Patients With Recent Acute-Onset Chest Pain.

Mathias H Sørgaard1, Jesper J Linde1, J Tobias Kühl2, Henning Kelbæk3, Jens D Hove4, Gitte G Fornitz5, Tem B S Jørgensen5, Merete Heitmann2, Charlotte Kragelund6, Thomas F Hansen7, Jawdat Abdulla8, Thomas Engstrøm1, Jan S Jensen7, Yaffah T Wiegandt1, Dan E Høfsten1, Lars V Køber1, Klaus F Kofoed9.   

Abstract

OBJECTIVES: The authors sought to perform a randomized controlled trial to evaluate the clinical efficacy of combined examination with coronary computed tomography angiography (CTA) and computed tomography perfusion imaging (CTP) compared to coronary CTA alone.
BACKGROUND: Stress myocardial CTP may increase diagnostic specificity when added to coronary CTA in patients suspected of having ischemic heart disease.
METHODS: Patients recently hospitalized for acute-onset chest pain, who had acute coronary syndrome had been ruled out by normal electrocardiograms, normal troponin levels, and relief of symptoms, and who had a clinical indication for outpatient noninvasive testing, were screened for inclusion in the CATCH-2 (CArdiac cT in the treatment of acute CHest pain 2) trial (NCT02014311). Patients were randomized 1:1 to examination with coronary CTA or coronary CTA+CTP. The primary endpoint was the frequency of coronary revascularization among patients referred for invasive coronary angiography (ICA) based on index computed tomography evaluation. Secondary endpoints were invasive procedural complications at index-related ICA, post-index cardiac death, hospital admittance because of recurrence of chest pain, unstable angina pectoris, or acute myocardial infarction, ICA, and revascularization.
RESULTS: Among 300 patients allocated to the coronary CTA+CTP group, 41 (14%) were referred for ICA compared with 89 (30%) allocated to coronary CTA (p < 0.0001). The primary endpoint occurred in 50% of coronary CTA+CTP patients versus 48% of invasively examined patients (p = 0.85). The total number of revascularizations was significantly lower in the coronary CTA+CTP group compared to the coronary CTA group (n = 20 [7%] vs. n = 42 [14%]; p = 0.0045). At median follow-up of 1.5 years, the occurrence of secondary endpoints was similar in the 2 groups.
CONCLUSIONS: A post-discharge diagnostic strategy of coronary CTA+CTP safely reduces the need for invasive examination and treatment in patients suspected of having ischemic heart disease. (CArdiac cT in the treatment of acute CHest pain 2-Myocardial CT Perfusion [CATCH2]; NCT02014311).
Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  chest pain; ischemia; noninvasive imaging; outcome; revascularization

Mesh:

Year:  2017        PMID: 29248654     DOI: 10.1016/j.jcmg.2017.09.022

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  4 in total

Review 1.  Functional cardiac CT-Going beyond Anatomical Evaluation of Coronary Artery Disease with Cine CT, CT-FFR, CT Perfusion and Machine Learning.

Authors:  Joyce Peper; Dominika Suchá; Martin Swaans; Tim Leiner
Journal:  Br J Radiol       Date:  2020-08-12       Impact factor: 3.039

Review 2.  Cardiac CT: why, when, and how : Update 2019.

Authors:  Anke Busse; Daniel Cantré; Ebba Beller; Felix Streckenbach; Alper Öner; Hüseyin Ince; Marc-André Weber; Felix G Meinel
Journal:  Radiologe       Date:  2019-12       Impact factor: 0.635

Review 3.  CT Myocardial Perfusion Imaging: A New Frontier in Cardiac Imaging.

Authors:  Sara Seitun; Cecilia De Lorenzi; Filippo Cademartiri; Angelo Buscaglia; Nicole Travaglio; Manrico Balbi; Gian Paolo Bezante
Journal:  Biomed Res Int       Date:  2018-10-14       Impact factor: 3.411

4.  Clinical quantitative cardiac imaging for the assessment of myocardial ischaemia.

Authors:  Marc Dewey; Maria Siebes; Marc Kachelrieß; Klaus F Kofoed; Pál Maurovich-Horvat; Konstantin Nikolaou; Wenjia Bai; Andreas Kofler; Robert Manka; Sebastian Kozerke; Amedeo Chiribiri; Tobias Schaeffter; Florian Michallek; Frank Bengel; Stephan Nekolla; Paul Knaapen; Mark Lubberink; Roxy Senior; Meng-Xing Tang; Jan J Piek; Tim van de Hoef; Johannes Martens; Laura Schreiber
Journal:  Nat Rev Cardiol       Date:  2020-02-24       Impact factor: 32.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.